1 / 23

Pulmonary Hypertension: Overview

Pulmonary Hypertension: Overview. Pulmonary Hypertension (PH) is an under-recognized disease PH is estimated to be the third most common cardiovascular syndrome Is the result of pulmonary, cardiac, infectious, and connective tissue disease Treatment varies based on etiology.

tate
Download Presentation

Pulmonary Hypertension: Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pulmonary Hypertension: Overview • Pulmonary Hypertension (PH) is an under-recognized disease • PH is estimated to be the third most common cardiovascular syndrome • Is the result of pulmonary, cardiac, infectious, and connective tissue disease • Treatment varies based on etiology

  2. Pulmonary Arterial Hypertension: Definition • Pulmonary arterial hypertension (PAH) is a progressive, incurable disease of the small pulmonary arteries characterized by vascular cell proliferation, aberrant remodeling, and thrombosis in situ • PH is defined as a combination of: • Mean pulmonary artery pressure > or =25mmHg at rest • Mean pulmonary artery pressure > or =30mmHg with exercise

  3. Vascular Pressure in Systemic and Pulmonary Circulations (mm Hg) 120/80, mean 90 25/10, mean 15 Systemic Circulation Pulmonary Circulation Arteries Arteries Right Atrium Mean >6 Left Atrium Mean 5 Body Lung SVR= 17.6PVR= 1.8 Right Ventricle 25/5 Left Ventricle 120/5 Veins Veins

  4. WHO Clinical Classification of PH • Group 1. Pulmonary arterial hypertension • Group 2. Pulmonary venous hypertension • Group 3. PH associated with disorders of the respiratory system and/or hypoxemia • Group 4. PH due to chronic thromboembolic disease • Group 5. Miscellaneous

  5. KDMC Statistics FY 08 415.0-415.9 (Acute Pulm Heart Disease – includes Cor Pulmonale, Pulm Embolism) 416.8 (PH, Secondary) 416.0 – 416.9 (Chronic Pulm Heart Disease – includes all types of PH, Cor Pulmonale)

  6. KDMC Statistics FY07 – FY08 Outpatient Inpatient Emergency Department

  7. Appropriate Patient for Referral • Echo revealing: • Pulmonary Artery (PA) Systolic Pressure > 40mmHg • PA Systolic pressures between 35-40 mmHg when patient is symptomatic • Right Heart Cath revealing: • Sustained Mean PA Pressure >25mmHg at rest or >30 mmHg with exercise • Mean pulmonary-capillary wedge pressure and left ventricular end-diastolic pressure <15 mmHg

  8. Appropriate Patient for Referral • CXR revealing pulmonary artery enlargement or pruning • EKG showing Right Ventricular strain

  9. Required Documentation/Testing • Detailed Physician H&P • Complete PFT • VQ Scan • CXR • Echo

  10. Initial Clinic Visit • Assessment • 12 lead EKG • 6 Minute Walk Test • Patient Education • Additional Testing ordered as indicated • Testing will be coordinated for minimal patient inconvenience

  11. Radiology HRCT of Thorax Pulmonary Angiogram Labs: CBC with platelets BMP LFTs BNPEP Thyroid Function Panel ANA screen RF Sed Rate CRP Scl-70 PT/INR Hypercoagulability Panel HIV Antiphospholipid Antibodies Sleep Study Right Heart Cath Possible Additional Testing

  12. Follow up Clinic Visit • All testing will be evaluated • Patient follow up evaluation • Diagnosis including WHO Group and Functional Class • Treatment Plan initiated • Continual patient education • Letter to referring physician detailing findings and treatment plan

  13. Multi-Departmental Support Echo Lab • Things to obtain and focus on when performing and interpreting ALL Echocardiograms • A global evaluation of right heart structure and function • Right Ventricular systolic pressures • Right Atrial and/or Ventricular enlargement • Diastolic Dysfunction • Valvular Heart Disease, e.g. TR • Ejection fraction • Pericardial disease / Pericardial effusion

  14. Multi-Departmental Support • Cath Lab • Right Heart Cath protocols must be followed in order to diagnose and obtain treatment

  15. Right Heart Catheterization in PAH: Indications • Confirm presence of PH • Aid to determining etiology • Prognostication • Guide therapeutic choices, e.g. CCBs • Follow up therapeutic interventions

  16. RHC in PAH:Key Findings • PH: mean PAP ≥ 25mmHg at rest or ≥ 30 mmHg with exercise • PAWP <15 mmHg • PVR >3 Wood Units • Evidence of valvular heart disease • Evidence of left-sided dysfunction • Evidence of congenital heart disease

  17. RHC in PAHSpecial Procedures • Vasodilator administration • Fluid challenge • Exercise • Shunt evaluation

  18. Multi-Departmental Support • All Departments need to provide the best possible testing and timely reporting • These two aspects are crucial to treating these patients quickly and effectively

More Related